Gemcitabine Versus Docetaxel Plus Cisplatin as Induction Chemotherapy in Nasopharyngeal Carcinoma. Chen Q, Li S. Laryngoscope 2022 Mar 3. doi: 10.1002/lary.30092.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Chen Q, Li S. Gemcitabine Versus Docetaxel Plus Cisplatin as Induction Chemotherapy in Nasopharyngeal Carcinoma. Laryngoscope 2022 Mar 3. doi: 10.1002/lary.30092.
PMID: 35238403